Johnson & Johnson has spent three years trying to avoid facing 67,000+ talc lawsuits in court. Every strategy has failed. Now the cases are going to trial — and the verdicts are staggering.
The Bankruptcy Gambit Is Dead
J&J's strategy was audacious: create a subsidiary (LTL Management), load it with the talc liabilities, then file for bankruptcy to force a capped settlement on all claimants.
It didn't work. Three times.
In March 2025, a bankruptcy judge rejected J&J's $10 billion settlement proposal — the third failed attempt to resolve the litigation through Chapter 11. J&J has now abandoned the bankruptcy strategy entirely and will face claims in open court.
The Verdicts Are Massive
With the bankruptcy shield gone, juries are weighing in:
- $1.5 billion (December 22, 2025): Baltimore jury awarded to Cherie Craft for peritoneal mesothelioma — approximately $59.8 million in compensatory damages with the remainder in punitive damages
- $65.5 million (December 2025): Minnesota jury award for a mesothelioma case
- $40 million (December 2025): California jury award for two women with ovarian cancer
These aren't outlier verdicts. They're a pattern. And they set the tone for settlement negotiations across the remaining 67,000+ cases.
What Makes Talc the Largest Active Mass Tort
By pure case count, talc is the biggest mass tort in America:
| Mass Tort | Pending Cases |
|---|---|
| Talcum Powder (J&J) | 67,600 |
| Hernia Mesh | 24,000 |
| AFFF/PFAS | 15,200 |
| Hair Relaxers | 11,195 - 15,000 |
| Proton-Pump Inhibitors | 11,300 |
| GLP-1 Drugs | 3,546 |
The court has now appointed Lead Negotiation Counsel and a Plaintiffs' Negotiation Committee — a strong signal that structured settlement talks are imminent.
LEWS Intelligence on Talc
LEWS tracks talc as one of our known MDL products (MDL 2738). Our system monitors:
- New court filings and docket activity via CourtListener
- Scientific literature on talc-asbestos contamination and cancer causation
- Regulatory actions and FDA enforcement related to cosmetic talc
- News coverage and attorney advertising patterns
The data shows that while talc litigation is mature, it's far from resolved. The combination of massive case volume, no global settlement, and escalating jury verdicts creates ongoing opportunities — particularly for firms that can identify and sign mesothelioma cases, which command the highest individual values.
What Happens Next
J&J faces a choice: settle on plaintiffs' terms or endure a years-long trial calendar with billion-dollar verdict risk. The smart money says settlement, but J&J's track record suggests they'll fight longer than expected.
For plaintiff firms, the key metrics to watch are:
- Progress of the Plaintiffs' Negotiation Committee talks
- Upcoming trial dates and venue selections
- Whether J&J attempts a fourth bankruptcy strategy (unlikely but not impossible)
- Individual case valuations as more verdicts come in
LEWS tracks 25+ active MDLs including talc, PFAS, GLP-1, and hair relaxers. Our system monitors court filings, regulatory actions, and scientific evidence to keep plaintiff firms informed on every major mass tort
Learn more